Paid Clinical Trials Jersey City

Discover 1,568 paid clinical trials in Jersey City, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,568

A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host DiseaseA Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

Hackensack NJ, Boston MA, Toronto, Greenville SCshow 3 more

Code:

NCT06585774

Conditions

Chronic Graft-versus-host-disease

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

INCA034176

Placebo

Corticosteroids

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell LymphomaA Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma

Recruiting

PHASE3

Sponsor:

Regeneron Pharmaceuticals

Location:

Westbury NY, New Brunswick NJ, Stony Brook NY, Boston MAshow 13 more

Code:

NCT06091865

Conditions

Diffuse Large B-cell Lymphoma (DLBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Odronextamab

Rituximab

Cyclophosphamide

Doxorubicin

Vincristine

A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerA Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

New York NY, New Brunswick NJ, Bala-Cynwyd PA, Lancaster PAshow 29 more

Code:

NCT06319820

Conditions

Non-Muscle Invasive Bladder Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

TAR-210

Gemcitabine

MMC

Oral Acetaminophen for Post-Op Pain Management in Bariatric Surgery PatientsOral Acetaminophen for Post-Op Pain Management in Bariatric Surgery Patients

Recruiting

PHASE2

Sponsor:

Rutgers, The State University of New Jersey

Location:

New Brunswick NJ

Code:

NCT06658574

Conditions

Post Operative Analgesia

Bariatric Surgery

Bariatric Surgery (Gastric Bypass)

Bariatric Surgery Patients

Perioperative Analgesia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Acetaminophen

A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2)

Recruiting

PHASE3

Sponsor:

Incyte Corporation

Location:

New York NY, Brooklyn NY, Hackensack NJ, Bronx NYshow 47 more

Code:

NCT06516965

Conditions

Prurigo Nodularis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Povorcitinib

Placebo

Safety and Efficacy of VDPHL01 in Males and Females with AGASafety and Efficacy of VDPHL01 in Males and Females with AGA

Recruiting

PHASE2

Sponsor:

Veradermics, Inc.

Location:

Hackensack NJ, New Albany IN, South Jordan UT, San Diego CA

Code:

NCT06527365

Conditions

Androgenetic Alopecia

AGA

Male Pattern Baldness

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

VDPHL01

Measuring Pain Experience in Individuals With Lateral Elbow TendinopathyMeasuring Pain Experience in Individuals With Lateral Elbow Tendinopathy

Recruiting

Sponsor:

Thomas Jefferson University

Location:

Fairless Hills PA, Langhorne PA, Warminster PA, Torresdale PAshow 9 more

Code:

NCT06025565

Conditions

Elbow Tendinopathy

Tendinopathy

Tennis Elbow

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pain Experience Measures

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory ConditionA Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

Recruiting

PHASE2

Sponsor:

Memorial Sloan Kettering Cancer Center

Location:

New York NY, Rockville Centre NY, Middletown NJ, Montvale NJshow 6 more

Code:

NCT05787574

Conditions

Primary Immune Regulatory Disorder

Autoimmune Lymphoproliferative

Immune System Diseases

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Interventions

Emapalumab

Fludarabine and Dexamethasone

Stem Cell Transplant

Study with Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure with Severely Reduced Ejection FractionStudy with Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure with Severely Reduced Ejection Fraction

Recruiting

PHASE3

Sponsor:

Cytokinetics

Location:

Bridgewater NJ, Camp Hill PA, Greensboro NC, Marion OHshow 9 more

Code:

NCT06736574

Conditions

Heart Failure

Heart Failure with Reduced Ejection Fraction

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Omecamtiv Mecarbil (OM)

Placebo

A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabA Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without Ibalizumab

Recruiting

Sponsor:

Theratechnologies

Location:

Newark NJ, Hillsborough NJ, Stamford CT, New Haven CTshow 21 more

Code:

NCT05388474

Conditions

HIV Infections

Multi-Antiviral Resistance

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

No ibalizumab or Pre-ibalizumab treatment

On ibalizumab treatment